News Conference News ESC 2018 Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI Michael O'Riordan August 25, 2018
News Daily News Edoxaban Looks Good for Asians With A-fib in Real-world Analysis Todd Neale August 14, 2018
News Daily News Intracranial Hemorrhage Outside of A-fib: Different NOACs, Different Risks Todd Neale August 13, 2018
News Daily News Ischemic Stroke Risk Scoring May Not Be Accurate for Patients With Atrial Flutter L.A. McKeown August 03, 2018
News Daily News New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI Michael O'Riordan July 31, 2018
News Daily News Asian Patients With A-fib Don’t Gain Anything From Low-Dose Rivaroxaban Todd Neale July 24, 2018
News Daily News Chew on This: Review Tackles Controversies in Nutrition for CV Health Lucy Hicks July 23, 2018
News Daily News Multivitamin and Mineral Supplements Don’t Stave Off Heart Disease or Stroke: Meta-analysis Caitlin E. Cox July 13, 2018
News Daily News NOACs Particularly Beneficial for Women With A-fib, Study Suggests Todd Neale July 11, 2018
News Daily News Bleeding Risk Increased With NSAID Use in Anticoagulated A-fib Patients: RE-LY Analysis L.A. McKeown July 10, 2018
News Daily News Real-world Analysis Suggests Apixaban Is Safest of the NOACs, Even for Patients With A-fib L.A. McKeown July 06, 2018
News Daily News Burden of Anticoagulation Can Be Reduced in Some Patients With Mechanical Valves L.A. McKeown June 12, 2018
News Daily News NAVIGATE ESUS: Rivaroxaban Fails to Prevent More Recurrent Cryptogenic Strokes Than Aspirin L.A. McKeown May 16, 2018
News Conference News HRS 2018 Thrombus on the Watchman LAA Occluder Tied to Higher Stroke Risk Todd Neale May 14, 2018
News Conference News HRS 2018 NOACs Perform Worse Than Warfarin in Real-World Study, Especially When Adherence Is Low Todd Neale May 11, 2018
News Daily News Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval Todd Neale May 04, 2018
News Daily News Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval Michael O'Riordan May 01, 2018